Literature DB >> 11801526

Androgen induction of in vitro prostate cell differentiation.

David C Whitacre1, Sanjay Chauhan, Tracy Davis, Debra Gordon, Anne E Cress, Roger L Miesfeld.   

Abstract

To better understand androgen action in normal prostate cells, we characterized the androgen growth response of an immortalized nontumorigenic rat prostate cell line called CA25 that had been stably transfected with androgen receptor (AR) cDNA. Surprisingly, we found that AR(+) CA25 cells grew slower in the presence of dihydrotestosterone (DHT), whereas the growth of AR(-) CA25 cells was not affected by the hormone. DHT-mediated growth inhibition of CA25 cells was not attributable to an increase in apoptosis but rather to a morphological conversion consistent with terminal differentiation. Specifically, we found that DHT treatment of CA25 cells resulted in a striking change in cell architecture, localization of desmoplakin to cell-cell boundaries, and an increase in alpha 6p integrin levels, a newly described marker of cell differentiation. Although no androgen-dependent changes were observed in the transcript levels of the mitochondrial aspartate aminotransferase or c-Myc genes by Northern blot analysis, RNA expression profiling of DHT-treated CA25 cells identified 282 genes of 1,018 that were continually expressed over a 48-h period. It was found that 63 of these genes were up-regulated >5-fold within the first 4 h of treatment and encoded functions involved in transport, signal transduction, and metabolism. These expression profile data are consistent with the striking morphological changes we observed in DHT-treated CA25 cells and provide a starting point for molecular analysis of in vitro prostate cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11801526

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  32 in total

1.  The program of androgen-responsive genes in neoplastic prostate epithelium.

Authors:  Peter S Nelson; Nigel Clegg; Hugh Arnold; Camari Ferguson; Michael Bonham; James White; Leroy Hood; Biaoyang Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-16       Impact factor: 11.205

2.  Human stroma and epithelium co-culture in a microfluidic model of a human prostate gland.

Authors:  L Jiang; F Ivich; S Tahsin; M Tran; S B Frank; C K Miranti; Y Zohar
Journal:  Biomicrofluidics       Date:  2019-11-20       Impact factor: 2.800

3.  Intracellular modifiers of integrin alpha 6p production in aggressive prostate and breast cancer cell lines.

Authors:  Apollo D Kacsinta; Cynthia S Rubenstein; Isis C Sroka; Sangita Pawar; Jaime M Gard; Raymond B Nagle; Anne E Cress
Journal:  Biochem Biophys Res Commun       Date:  2014-10-22       Impact factor: 3.575

4.  JunD-mediated repression of GADD45α and γ regulates escape from cell death in prostate cancer.

Authors:  Luiz Fernando Zerbini; Jaíra Ferreira de Vasconcellos; Akos Czibere; Yihong Wang; Juliano D Paccez; Xuesong Gu; Jin-Rong Zhou; Towia A Libermann
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

5.  Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70.

Authors:  Yi Peng; Caihong X Li; Fei Chen; Zhengxin Wang; Martin Ligr; Jonathan Melamed; Jianjun Wei; William Gerald; Michele Pagano; Michael J Garabedian; Peng Lee
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

6.  A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer.

Authors:  Russell Szmulewitz; Supriya Mohile; Edwin Posadas; Rangesh Kunnavakkam; Theodore Karrison; Elizabeth Manchen; Walter M Stadler
Journal:  Eur Urol       Date:  2009-02-27       Impact factor: 20.096

7.  Distinct nuclear and cytoplasmic functions of androgen receptor cofactor p44 and association with androgen-independent prostate cancer.

Authors:  Yi Peng; Fei Chen; Jonathan Melamed; Luis Chiriboga; Jianjun Wei; Xiangtian Kong; Maureen McLeod; Yirong Li; Caihong X Li; Alice Feng; Michael J Garabedian; Zhengxin Wang; Robert G Roeder; Peng Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-20       Impact factor: 11.205

8.  5alpha-androstane-3alpha,17beta-diol selectively activates the canonical PI3K/AKT pathway: a bioinformatics-based evidence for androgen-activated cytoplasmic signaling.

Authors:  Mikhail G Dozmorov; Qing Yang; Adam Matwalli; Robert E Hurst; Daniel J Culkin; Bradley P Kropp; Hsueh-Kung Lin
Journal:  Genomic Med       Date:  2008-02-27

9.  Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo.

Authors:  Thomas Nelius; Stephanie Filleur; Alexander Yemelyanov; Irina Budunova; E Shroff; Yelena Mirochnik; Arin Aurora; Dorina Veliceasa; Wuhan Xiao; Zhou Wang; Olga V Volpert
Journal:  Int J Cancer       Date:  2007-09-01       Impact factor: 7.396

10.  An AR-Skp2 pathway for proliferation of androgen-dependent prostate-cancer cells.

Authors:  Hongbo Wang; Daqian Sun; Peng Ji; James Mohler; Liang Zhu
Journal:  J Cell Sci       Date:  2008-07-15       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.